MONTREAL, June 20, 2022 /PRNewswire/ - Aifred Health, an award-winning digital healthcare company, today announced the treatment of the first patient in its 350 patient North American Clinical Trial. This
Aifred Health among top three finalists in IBM Watson AI XPRIZE competition
Aifred Health, a Montréal-based startup that offers clinical solutions for mental health treatments using artificial intelligence (AI), has been selected as one of three finalists for the IBM Watson AI XPRIZE.
AI XPrize is a five-year competition with three judging rounds. Montréal-based Aifred Health was one of more than 700 applicants for the competition, which is aimed at encouraging the use of AI to solve challenges faced around the world.
“To be named as one of the top three global AI teams in the world is an incredible accomplishment and endorsement.”
Aifred Health Named Top 3 Finalist in Global IBM Watson AI XPRIZE Competition
News provided by
Share this article
Share this article
MONTREAL, Feb. 16, 2021 /PRNewswire/ - Aifred Health announced today that the XPRIZE jury has selected Aifred Health as one of the 3 finalists for the IBM Watson AI XPRIZE. The company is competing for the grand prize of US$3.0 million which will be awarded in June, 2021, with 2nd and 3rd prize winners receiving US$1.0 million and US$0.5 million respectively.
Montreal-based Aifred Health was one of more than 700 applicants for this XPRIZE focused on employing AI to solve the world s grand challenges. Teams were judged by world-leading experts in AI who conducted extensive due diligence and reviews of each team s application and their ability to meet the key criteria of achieved technical impact; evidenced real-world impact; scalability of real-world impact; and ethics and safety.